Follow
Chimeric antigens
Antigens are foreign substances that induce the body to generate an immune response and produce antibodies. The better the immune system can recognize antigens, the more effective immune response it can mount. Chimeric antigens are specially engineered proteins that designed to improve the ability of immune cells to target a specific disease-associated antigen.
-
JUL 17, 2017Cancer
Scientists are putting a target on cancer’s back, and immune cells are being trained to track down and kill that t ...Written By: Kara MarkerAPR 06, 2017Videos
While research and testing for new cancer drugs is vital, it also takes time. A new treatment that has shown promise in ...Written By: Brenda Kelley KimJAN 27, 2017Cell & Molecular Biology
Several years after receiving the treatment, scientists have confirmed that two infants with cancer that received a type ...Written By: Carmen LeitchDEC 07, 2016Microbiology
Nobody likes going to the dentist, but most of us do it anyway. Why? Because regular dental care helps prevent thi ...Written By: Kerry EvansAUG 01, 2016Immunology
A new treatment for the selective targeting of ovarian cancer cells has been adopted from chimeric antigen receptor (CAR ...Written By: Kara MarkerJUL 19, 2016Cancer
A decade-old technology to arm the immune system to fight cancer is now being adapted to fight HIV, one of the most pern ...JUN 27, 2016Immunology
T cells are the body’s natural fleet of cancer-attacking lymphocytes, but in recent years scientists have found a ...Written By: Kara MarkerJUN 01, 2016Immunology
The 1990s was an exciting time for cancer research, as scientists genetically engineered the very first chimeric antigen ...Written By: Kara MarkerAPR 30, 2016Cancer
Researchers recently reported that immunotherapy led to remission in 93 percent of patients with advanced leukemia. Thou ...FEB 18, 2016Health & Medicine
Dramatic remissions have been seen in a cancer immunotherapy trial for patients with blood cancers. Specifically, ...Written By: Julianne ChiaetNOV 02, 2015Immunology
B-cell leukemia occurs in 80-85 percent of children with acute lymphoblastic leukemia (ALL), a fast-growing cancer that ...Written By: Kara MarkerSEP 29, 2015Cancer
UC San Francisco scientists have developed a molecular “on switch” enabling tight control over the acti ...Written By: Ilene SchneiderSEP 13, 2015Cancer
A team at the University of Pennsylvania reported that a multiple myeloma patient whose cancer had stopped respondi ...Written By: Ilene SchneiderFEB 27, 2015Genetics & Genomics
Genetically engineered T memory stem cells (Tscm) can last more than 12 years in patients' bodies, and can continually g ...Written By: Ilene SchneiderFEB 26, 2015Cancer
A study published in Science Translational Medicine showed that immune cells engineered to seek out and attack a type of ...Written By: Ilene Schneider
JUL 17, 2017
Cancer
Scientists are putting a target on cancer’s back, and immune cells are being trained to track down and kill that t
...
Written By:
Kara Marker
APR 06, 2017
Videos
While research and testing for new cancer drugs is vital, it also takes time. A new treatment that has shown promise in
...
Written By:
Brenda Kelley Kim
JAN 27, 2017
Cell & Molecular Biology
Several years after receiving the treatment, scientists have confirmed that two infants with cancer that received a type
...
Written By:
Carmen Leitch
DEC 07, 2016
Microbiology
Nobody likes going to the dentist, but most of us do it anyway. Why? Because regular dental care helps prevent thi
...
Written By:
Kerry Evans
AUG 01, 2016
Immunology
A new treatment for the selective targeting of ovarian cancer cells has been adopted from chimeric antigen receptor (CAR
...
Written By:
Kara Marker
JUL 19, 2016
Cancer
A decade-old technology to arm the immune system to fight cancer is now being adapted to fight HIV, one of the most pern
...
JUN 27, 2016
Immunology
T cells are the body’s natural fleet of cancer-attacking lymphocytes, but in recent years scientists have found a
...
Written By:
Kara Marker
JUN 01, 2016
Immunology
The 1990s was an exciting time for cancer research, as scientists genetically engineered the very first chimeric antigen
...
Written By:
Kara Marker
APR 30, 2016
Cancer
Researchers recently reported that immunotherapy led to remission in 93 percent of patients with advanced leukemia. Thou
...
FEB 18, 2016
Health & Medicine
Dramatic remissions have been seen in a cancer immunotherapy trial for patients with blood cancers. Specifically,
...
Written By:
Julianne Chiaet
NOV 02, 2015
Immunology
B-cell leukemia occurs in 80-85 percent of children with acute lymphoblastic leukemia (ALL), a fast-growing cancer that
...
Written By:
Kara Marker
SEP 29, 2015
Cancer
UC San Francisco scientists have developed a molecular “on switch” enabling tight control over the acti
...
Written By:
Ilene Schneider
SEP 13, 2015
Cancer
A team at the University of Pennsylvania reported that a multiple myeloma patient whose cancer had stopped respondi
...
Written By:
Ilene Schneider
FEB 27, 2015
Genetics & Genomics
Genetically engineered T memory stem cells (Tscm) can last more than 12 years in patients' bodies, and can continually g
...
Written By:
Ilene Schneider
FEB 26, 2015
Cancer
A study published in Science Translational Medicine showed that immune cells engineered to seek out and attack a type of
...
Written By:
Ilene Schneider